Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

BioMimetic completes enrollment into clinical trial of Augment Bone Graft

Jan. 12, 2009

Imatinib prevents, reverses diabetes in nonobese mice

Jan. 12, 2009

Janssen has synthesized novel DGAT-1 inhibitors with potental as antidiabetic agents

Jan. 9, 2009

Warner Chilcott and Dong-A sign U.S. license agreement for udenafil in erectile dysfunction

Jan. 9, 2009

Phosphagenics reports results from trial of TPM/insulin in diabetic patients

Jan. 9, 2009

Bayer Schering Pharma submits Visanne for registration in Europe for endometriosis

Jan. 8, 2009

Novel ghrelin receptor ligands under development at GSK for treatment of obesity

Jan. 8, 2009

Novel DGAT-1 inhibitors discovered by Janssen researchers

Jan. 8, 2009

Cytochroma commences phase I CTAP-201 injection in chronic kidney disease

Jan. 8, 2009

Galapagos selects preclinical candidate, G-100192, for cachexia program

Jan. 7, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...